EverHint – EMA10 × EMA30 Crossover – Top 10 Buy and Top 10 Sell Signals for Feb 13, 2026
What This Signal Is (Quick)
This strategy detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30):
-
Buy Signal (EMA10_x_EMA30_Buy): EMA(10) crosses above EMA(30) on today's close
- Short-term momentum overtakes medium-term trend
- Suggests acceleration in upward price movement
- Ideal for swing trading (1-4 week holding periods)
-
Sell Signal (EMA10_x_EMA30_Sell): EMA(10) crosses below EMA(30) on today's close
- Short-term momentum weakens below medium-term trend
- Suggests deceleration or reversal of upward movement
- Can signal exit points or short entry opportunities
Key Characteristics:
- Uses two EMAs (both exponential) for faster response to price changes
- More responsive than EMA10 x SMA50, generating more frequent signals
- Better suited for capturing short-to-medium term momentum shifts
- Higher sensitivity means more signals but also higher whipsaw risk in choppy markets
Key Criteria:
-
Buy: EMA10 crosses above EMA30
-
Sell: EMA10 crosses below EMA30
-
Minimum ADV: $40M (liquidity filter)
-
Earnings buffer: 7 days pre/post earnings
-
Fresh crossover: Detected on today's close
Holding Period: 1-4 weeks
Risk Level: Medium
How We Ranked Today
Ranked by RSI (lower RSI for buy signals = more oversold)
📈 Buy-Side Signals (Top 10 of 16 total)
Ranked by RSI (lower RSI for buy signals = more oversold):
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ZIM | ZIM Integrated Shippin... | Industrials | 22.20 | 44.8 | — | 26 | $-0.21 | 2.7 |
| 2 | WBD | Warner Bros. Discovery... | Communication Services | 27.99 | 46.2 | $-235K | 82 | $-0.32 | 69.4 |
| 3 | PRGO | Perrigo Company plc | Healthcare | 14.54 | 51.9 | — | 13 | $0.00 | 2.0 |
| 4 | ATAT | Atour Lifestyle Holdin... | Consumer Cyclical | 39.17 | 53.4 | — | 39 | $0.00 | 5.4 |
| 5 | FN | Fabrinet | Technology | 495.55 | 53.8 | $-4.7M | 80 | $19.07 | 17.8 |
| 6 | SWKS | Skyworks Solutions, Inc. | Technology | 62.10 | 55.6 | — | 81 | $5.86 | 9.3 |
| 7 | PFGC | Performance Food Group... | Consumer Defensive | 98.00 | 56.2 | — | 81 | $7.93 | 15.4 |
| 8 | ABVX | Abivax SA | Healthcare | 124.99 | 56.7 | — | 38 | $6.86 | 8.2 |
| 9 | AMSC | American Superconducto... | Industrials | 34.26 | 56.8 | — | — | $2.23 | 1.6 |
| 10 | RL | Ralph Lauren Corporation | Consumer Cyclical | 369.18 | 56.9 | — | — | $23.61 | 22.4 |
📉 Sell-Side Signals (Top 10 of 25 total)
Ranked by RSI (higher RSI for sell signals = more overbought):
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SONO | Sonos, Inc. | Technology | 15.51 | 54.1 | $+12.6M | 81 | $0.49 | 1.9 |
| 2 | BAC | Bank of America Corpor... | Financial Services | 52.55 | 52.6 | — | 61 | $6.82 | 383.7 |
| 3 | CDW | CDW Corporation | Technology | 126.86 | 49.3 | — | 81 | $12.10 | 16.5 |
| 4 | ESS | Essex Property Trust, ... | Real Estate | 251.16 | 48.1 | — | 73 | $0.00 | 16.2 |
| 5 | QSR | Restaurant Brands Inte... | Consumer Cyclical | 66.14 | 45.5 | — | 82 | $5.31 | 21.8 |
| 6 | COGT | Cogent Biosciences, Inc. | Healthcare | 36.53 | 44.1 | $-127.4M | 80 | $2.43 | 5.6 |
| 7 | SNY | Sanofi | Healthcare | 46.01 | 43.3 | — | 68 | $6.06 | 111.8 |
| 8 | DRS | Leonardo DRS, Inc. | Industrials | 38.13 | 41.6 | $-722K | 75 | $1.65 | 10.1 |
| 9 | AMP | Ameriprise Financial, ... | Financial Services | 473.67 | 41.3 | $-8.6M | 68 | $59.95 | 44.0 |
| 10 | XMTR | Xometry, Inc. | Industrials | 55.42 | 40.7 | — | 80 | $0.00 | 2.8 |
Field Notes
Sector concentration: Technology (10), Industrials (7), Financial Services (6)
Insider selling: AMP (Ameriprise Financial, Inc., $-8.6M), COGT (Cogent Biosciences, Inc., $-127.4M), RBA (RB Global, Inc., $-2.4M)
Insider buying: SONO (Sonos, Inc., $+12.6M), BHVN (Biohaven Ltd., $+145K)
Near-term earnings: BIDU (Baidu, Inc.) report within 7 days. Higher volatility risk.
Data coverage: 29.3% insider, 2.4% congressional (1 recent/90d), 92.7% earnings, 100.0% analyst, 43.9% news
Peer Analysis
Understanding how these stocks relate to their industry peers:
ZIM (ZIM Integrated Shipping Service): Leads 9 peers: CMBT ($12.85, +2.5%), DAC ($108.05, +2.8%), BWLP ($16.73, +1.3%), SBLK ($23.80, +2.5%), CDLR ($25.90, +0.8%) | Peer of: BWLP ($16.73, +1.3%), CDLR ($25.90, +0.8%), CMBT ($12.85, +2.5%) and 8 more
PFGC (Performance Food Group Company): Leads 8 peers: USFD ($99.93, -2.0%), KOF ($112.74, -1.3%), MKC ($71.49, -0.2%), CELH ($44.68, +0.7%), TSN ($63.94, +1.0%) | Peer of: BF-B ($29.95, -2.4%), CELH ($44.68, +0.7%), CLX ($125.94, +1.0%) and 4 more
SWKS (Skyworks Solutions, Inc.): Leads 9 peers: RMBS ($101.95, +6.4%), MTSI ($244.16, +2.2%), AMKR ($47.48, -8.0%), NVMI ($443.76, +0.1%), TSEM ($128.74, -3.6%) | Peer of: AMKR ($47.48, -8.0%), CACI ($573.30, +2.1%), ENTG ($131.43, +0.4%) and 9 more
ABVX (Abivax SA): Leads 8 peers: RYTM ($98.07, +2.1%), CYTK ($66.26, +1.9%), AXSM ($181.21, -0.9%), HALO ($79.44, +3.3%), NUVL ($100.82, -0.5%) | Peer of: AXSM ($181.21, -0.9%), CORT ($39.97, +4.2%), CYTK ($66.26, +1.9%) and 7 more
COGT (Cogent Biosciences, Inc.): Leads 9 peers: RCUS ($18.92, -5.2%), IBRX ($5.95, -10.2%), DNLI ($18.77, -2.1%), GLPG ($33.92, +1.5%), LQDA ($38.20, -2.1%) | Peer of: AGIO ($27.96, -0.4%), AORT ($36.60, -10.0%), BEAM ($27.92, +3.7%) and 12 more
AMSC (American Superconductor Corpora): Leads 3 peers: SXI ($260.29, +1.8%), XMTR ($55.42, +2.4%), PSIX ($98.77, +6.5%) | Peer of: ATS ($31.18, +1.1%), KAI ($334.00, +0.1%), POWWP ($24.31, +0.1%) and 3 more
RL (Ralph Lauren Corporation): Leads 10 peers: IHG ($146.13, +0.2%), SW ($51.56, +0.3%), LULU ($176.42, +4.1%), CASY ($665.86, +0.3%), AMCR ($50.09, +0.7%) | Peer of: AMCR ($50.09, +0.7%), BURL ($302.37, +2.9%), CASY ($665.86, +0.3%) and 8 more
SNY (Sanofi): Leads 9 peers: PFE ($27.58, +0.4%), GILD ($154.98, +2.1%), GSK ($58.93, +0.7%), BMY ($60.74, +1.5%), MDT ($99.49, -1.4%) | Peer of: ABBV ($231.59, +1.8%), AMGN ($369.19, +0.8%), AZN ($205.55, +0.5%) and 16 more
DRS (Leonardo DRS, Inc.): Leads 7 peers: SARO ($30.57, +1.8%), UHAL ($49.69, +1.9%), DCI ($109.46, -0.4%), GNRC ($224.45, +4.0%), AIT ($279.84, +0.3%) | Peer of: AIT ($279.84, +0.3%), ARMK ($38.98, -0.5%), GE ($315.41, +0.8%) and 5 more
AMP (Ameriprise Financial, Inc.): Leads 9 peers: STT ($127.97, +1.3%), AIG ($78.27, -0.7%), APO ($125.07, -0.2%), NTRS ($146.38, +1.5%), BSBR ($6.59, -2.7%) | Peer of: AIG ($78.27, -0.7%), BEN ($27.03, -0.2%), BK ($117.74, +2.5%) and 4 more
ATAT (Atour Lifestyle Holdings Limite): Leads 10 peers: WH ($77.76, +0.1%), BOOT ($187.99, +1.1%), BFAM ($66.90, -18.2%), CHH ($110.04, +0.9%), LTH ($29.06, -0.8%) | Peer of: BFAM ($66.90, -18.2%), BOOT ($187.99, +1.1%), CAVA ($63.50, -0.2%) and 6 more
PRGO (Perrigo Company plc): Leads 9 peers: HCM ($14.76, +0.1%), BHC ($5.99, +2.6%), SUPN ($50.84, +2.0%), ATEC ($13.36, +2.0%), LIVN ($65.80, +3.0%) | Peer of: AMRX ($14.82, +1.3%), BHC ($5.99, +2.6%), HCM ($14.76, +0.1%) and 2 more
WBD (Warner Bros. Discovery, Inc. -): Leads 8 peers: LYV ($158.27, +2.2%), CMCSA ($31.57, -0.8%), LLYVK ($93.21, +1.6%), FOXA ($56.35, -0.1%), WMG ($29.45, +3.1%) | Peer of: BIDU ($137.01, -1.0%), NFLX ($76.87, +1.3%), RELX ($31.06, +7.8%)
ESS (Essex Property Trust, Inc.): Leads 7 peers: MAA ($135.55, +1.6%), INVH ($26.99, +0.6%), SUI ($130.79, +1.5%), NLY ($23.07, +0.6%), AMH ($31.62, +0.5%) | Peer of: ARE ($52.49, +4.2%), AVB ($176.19, +0.5%), BEKE ($17.55, -1.0%) and 7 more
XMTR (Xometry, Inc.): Leads 9 peers: HI ($31.98, +0.0%), EPAC ($43.02, +2.6%), ATS ($31.18, +1.1%), PCT ($8.69, -0.3%), NNE ($24.79, +0.0%) | Peer of: AMSC ($34.26, +7.2%), ATS ($31.18, +1.1%), ENVX ($5.92, +2.8%) and 4 more
CDW (CDW Corporation): Leads 10 peers: GIB ($74.53, -0.9%), IT ($158.58, +3.2%), LDOS ($176.30, +2.8%), CHKP ($171.48, +4.3%), SSNC ($72.09, +1.3%) | Peer of: ASTS ($82.51, +0.3%), BR ($173.70, +1.9%), CHKP ($171.48, +4.3%) and 12 more
FN (Fabrinet): Leads 10 peers: FTV ($56.90, +1.6%), TRMB ($66.40, +0.6%), MKSI ($260.74, +4.5%), DT ($37.20, +1.8%), GEN ($23.72, +0.7%) | Peer of: COHR ($217.23, +0.5%), FTV ($56.90, +1.6%), JBL ($254.58, +1.4%) and 4 more
QSR (Restaurant Brands International): Leads 10 peers: DRI ($211.50, -0.6%), YUMC ($55.42, +3.3%), LI ($18.46, -1.8%), DPZ ($375.50, -1.6%), ULTA ($683.40, +2.4%) | Peer of: CMG ($36.30, +1.3%), DRI ($211.50, -0.6%), EXPE ($212.67, -6.4%) and 10 more
BAC (Bank of America Corporation): Leads 7 peers: WFC ($86.98, +0.8%), HSBC ($85.15, -1.9%), RY ($169.47, +0.1%), C ($110.81, -0.3%), MUFG ($19.73, +0.7%) | Peer of: BRK-A ($748070.00, -0.2%), BRK-B ($497.55, -0.5%), C ($110.81, -0.3%) and 15 more
SONO (Sonos, Inc.): Leads 10 peers: MQ ($3.92, -2.5%), AAOI ($44.46, +1.1%), KN ($27.29, +2.4%), TDC ($33.56, +0.1%), PGY ($12.43, +0.2%) | Peer of: AAOI ($44.46, +1.1%), KN ($27.29, +2.4%), MQ ($3.92, -2.5%)
Congressional Activity
BABA (Alibaba Group Holding Limited) 🔴 Bearish (90d)
- 1 sale by 1 member
- Top seller: Hou. Dwight Evans (PA) - 1 transaction ($1,001 - $15,000)
Recent Headlines
AMP (Ameriprise Financial, Inc.)
- Ameriprise Financial, Inc. (AMP) Presents at Bank of America Financial Services Conference 2026 Transcript (source)
AMSC (American Superconductor Corpora)
- Why American Superconductor Corporation Rallied Over 20% This Week (source)
- How consumers are dealing with rising food prices, American Superconductor CEO on the US energy grid (source)
- American Superconductor: Story Still Has A Few Holes (Upgrade) (source)
BAC (Bank of America Corporation)
- BofA CEO Brian Moynihan's pay rises to $41 million (source)
- US bank regulators move closer to proposing new 'Basel' rules for large banks (source)
- Why Is Bank of America (BAC) Down 0.1% Since Last Earnings Report? (source)
- Berkshire Might Have Sold More Apple, Bank of America Stock in Fourth Quarter (source)
- How to Approach Wells Fargo Stocks as It Gains 14.2% in 6 Months? (source)
- BofA Community Development Banking Delivers $7.4 Billion in Financing, Creating 11,000+ Affordable Housing Units in 2025 (source)
- Atria Investments Inc Sells 33,636 Shares of Bank of America Corporation $BAC (source)
- Oil Market Faces 2 Million Barrel-per-Day Surplus, BofA's Blanch Says (source)
CDW (CDW Corporation)
- CDW Corporation: Still Waiting For The Growth Acceleration Catalyst To Come (source)
SNY (Sanofi)
- SNY Stock Falls After Board Suddenly Makes Leadership Change (source)
- Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors (source)
- First Look: Tech-led selloff, tariff shifts, AI funding boom (source)
- Sanofi's new CEO needs to fix drug pipeline and navigate Trump (source)
- Market Today: Tech Sells Off on AI Jitters; M&A, FDA Moves and Policy Shifts (source)
- Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued (source)
- Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor' (source)
- Who is Sanofi's new CEO Belén Garijo? (source)
- Sanofi Names Merck KGaA's Garijo to Replace Hudson as CEO (source)
- Sanofi appoints Belén Garijo as new CEO after deciding not to renew current CEO Hudson's mandate (source)
- Press Release: Belén Garijo to become Chief Executive Officer of Sanofi (source)
- Sanofi: Information concerning the total number of voting rights and shares – January 2026 (source)
- Press Release: Sanofi completes the acquisition of Dynavax (source)
- Press Release: Sanofi's rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia (source)
SONO (Sonos, Inc.)
- Allegheny Financial Group Makes New Investment in Sonos, Inc. $SONO (source)
WBD (Warner Bros. Discovery, Inc. -)
- Warner Bros Discovery sees activist Sachem Head increase stake in Q4 (source)
- Paramount eyes Pentwater Capital's Halbower for Warner Bros' board seat (source)
- The Biggest Obstacle to Netflix Acquiring Warner Bros. Discovery (Hint: It's Not Paramount) (source)
- Big Warner Bros. shareholders are getting restless in this Paramount-Netflix bidding war (source)
- First Look: McDonald's beats, Hims sued, WBD deal battle (source)
- Market Today: Jobs Beat Sways Stocks; MCD, WBD in Focus (source)
- Ancora threatens proxy fight over Warner Bros Discovery's acquisition deal with Netflix (source)
- Kraft Heinz Pauses Split, Paramount Sweetens Warner Bros. Bid | Bloomberg Deals 2/11/2026 (source)
- Activist investor Ancora publicly opposes the WBD-Netflix deal (source)
- Where the Battle for Warner Bros. Stands Now (source)
- Ancora threatens proxy fight over Warner Bros Discovery’s acquisition deal with Netflix (source)
- Chadwick: This is a once in a lifetime opportunity for Paramount (source)
- Activist Investor Slams WBD For Rushing Into “Flawed” Netflix Deal, Tells Board To Engage With Paramount As Temperature Rises (source)
- Warner Bros. Discovery faces activist investor who backs Paramount Skydance's rival bid over Netflix deal (source)
- First Look: Jobs Data Looms; WBD-NFLX Fight, Moderna Setback (source)
- Ancora Capital builds stake in Warner Bros, plans to oppose Netflix deal (source)
- Ancora Releases Presentation Regarding its Strong Opposition to the Currently Proposed WBD-Netflix Merger (source)
- Warner Bros. Gets an Activist, Report Says. (source)
- Activist investor Ancora pushes Warner Bros to walk away from Netflix deal, WSJ reports (source)
- Activist Investor Pushes Warner to Walk Away From Netflix Deal (source)
- Warner Bros. Discovery (WBD) Advances While Market Declines: Some Information for Investors (source)
- Here's why Warner Bros. Discovery might have to take a closer look at Paramount's ‘unsweet' bid (source)
- Tuesday's Final Takeaways: PSKY Sweetens WBD Takeover Bid & DDOG Rallies (source)
- Paramount sweetens its bid for Warner Bros. Discovery with ‘additional benefits' (source)
- Paramount Sweetens Its Hostile Bid for Warner Bros. (source)
- Paramount Skydance enhances Warner Bros acquisition offer to compete with Netflix (source)
- Warner Bros. Discovery Confirms Receipt of Further Amended Unsolicited Tender Offer from Paramount Skydance (source)
- Hasbro's (HAS) Strong Q4 Earnings Propel Stock Higher (source)
- Paramount sweetens deal further, but WBD may still reject it (source)
- Paramount still won't raise price for Warner Bros. bid but offers billions in ‘enhancements' (source)
- Paramount adds sweeteners to Warner Bros bid (source)
- What to know about Netflix's landmark acquisition of Warner Bros. (source)
- David Ellison kicks in a few billion more as he makes his 9th bid for Warner Bros. Discovery (source)
- Paramount Spruces Up Its Bid for Warner Discovery. Why It Might Not Move the Needle. (source)
- Paramount Sweetens Warner Offer (source)
- Paramount sweetens WBD offer as it vies to topple Netflix deal (source)
- Paramount Sweetens Offer For Warner Bros. Discovery (source)
- Paramount revises offer for Warner Bros with 25-cent ticking fee (source)
- Paramount sweetens WBD bid, but stops short of raising its per-share value (source)
- Paramount Enhances Its Superior $30 Per Share All-cash Offer For Warner Bros. Discovery And Provides Update On Regulatory Progress (source)
- Paramount Skydance enhances Warner Bros acquisition offer to compete with Netflix (source)
XMTR (Xometry, Inc.)
- Xometry to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (source)
ZIM (ZIM Integrated Shipping Service)
- ZIM Integrated Shipping Services (ZIM) Increases Yet Falls Behind Market: What Investors Need to Know (source)
Market Context
The market exhibits low directional conviction, with the S&P 500 edging up 0.01%, the Dow Jones flat at -0.00%, and the Nasdaq dipping 0.07%. This sideways grind suggests neutral trend direction, where ema10/ema30 crossover signals—reliant on short-term momentum shifts—may face increased whipsaw risk. Risk appetite appears subdued, as broad indices hover without strong bullish or bearish bias, potentially diluting the reliability of these trend-following signals amid choppy price action.
VIX at 20.60, down 4.10%, points to receding volatility, which could stabilize intraday swings and allow ema crossovers to hold better in nascent trends. However, lingering elevated levels relative to calmer periods imply caution, as any volatility spike could amplify false signals in this strategy, particularly with 41 total signals active.
Technology's dominance among signals aligns with sector rotation dynamics, but the Nasdaq's mild decline underscores potential underperformance in growth areas during this flat tape. Traders should monitor for rotation toward steadier sectors if risk appetite wanes further, tempering conviction in tech-heavy ema10/ema30 setups.
⚠️ Extended Non-Trading Period Alert
Important: The next 3 days (Saturday, February 14 through Monday, February 16) are non-trading days (weekend/holiday).
What this means:
- Markets will not reopen until Tuesday, February 17
- News and events occurring over this extended non-trading period may significantly influence market sentiment
- Monitor news flow closely during this period
- Be prepared for potential gaps or increased volatility when markets reopen
- Earnings announcements, geopolitical events, or major news during this period can lead to significant price movements at the open
- Consider adjusting position sizes or using protective stops given the extended gap risk
Vlad's Take (EverHint)
Today's signals: Strong sector concentration in Technology (10 signals) suggests sector-specific rotation. 2 signals with insider buying adds conviction. 10 signals showing insider selling warrant caution.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Sharing Call-to-Action
✅ If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/